By Cristina Roca

Sanofi SA (SAN.FR) said Thursday that it hired the head of Bayer AG's (BAYN.XE) pharmaceuticals division to lead its Primary Care unit, one of two new divisions that the French company is creating.

The French pharmaceutical group named Dieter Weinand to head the Primary Care unit, and also made him executive vice president, effective Nov. 1. Mr. Weinand joins Sanofi from Bayer, where he was a member of the board of management, the company said.

The Primary Care unit will combine the Diabetes and Cardiovascular unit with Established Products, which is currently part of a different division, Sanofi said. The head of the Diabetes and Cardiovascular unit, Stefan Oelrich, will leave Sanofi to join Bayer as a member of the German company's board of management and head of the pharmaceuticals division, effective Nov. 1, Sanofi said.

Sanofi said it also appointed Olivier Charmeil to lead its newly-created unit called China and Emerging Markets. Mr. Charmeil is currently head of another Sanofi unit and will remain on the Executive Committee, Sanofi said.

Write to Cristina Roca at cristina.roca@dowjones.com

(END) Dow Jones Newswires

September 13, 2018 07:14 ET (11:14 GMT)

Copyright (c) 2018 Dow Jones & Company, Inc.
Sanofi (EU:SAN)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024 Haga Click aquí para más Gráficas Sanofi.
Sanofi (EU:SAN)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024 Haga Click aquí para más Gráficas Sanofi.